Please assess the completion status of the following clinical trial:

Trial Title: Nerve Growth Factor for the Treatment of Cornea Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Patients diagnosed with LSCD and neurotrophic cornea confirmed by testing with Cochet-Bonnet aesthesiometer~Exclusion Criteria:~1. Active ocular infection~2. Anticipated need for bandage contact lens, amniotic membrane graft, or tarsorrhaphy during the study period~3. Unable to discontinue the use of contact lens~4. Visual acuity worse than 20/200 in the better eye

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).